Clotting risk not erased from AstraZeneca’s new jab | WHAT REALLY HAPPENED

Clotting risk not erased from AstraZeneca’s new jab

The risk of rare blood clots has not been eliminated from a new version of the Oxford-AstraZeneca vaccine now in clinical trials.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA